Regional Disparity in First-in-Class Anticancer Drug Development in the US, EU, and Japan-Reference-Cited by-同舟云学术

Regional Disparity in First-in-Class Anticancer Drug Development in the US, EU, and Japan

Published:2023-05-01 Issue:5 Volume:46 Page:700-706
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biological & Pharmaceutical Bulletin

Author:

Hino Yoshitsugu¹,Okada Miu¹,Hallgreen Christine Erikstrup²,De Bruin Marie Louise³,Doty Randell E⁴,Matsumaru Naoki¹,Tsukamoto Katsura¹

Affiliation:

1. Global Regulatory Science, Gifu Pharmaceutical University

2. Copenhagen Center for Regulatory Science, University of Copenhagen

3. Utrecht Centre for Pharmaceutical Policy and Regulation, Utrecht University

4. Pharmacotherapy & Translational Research, College of Pharmacy, University of Florida

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/46/5/46_b22-00868/_pdf

Reference27 articles.

1. 1) OECD. “Cancer incidence and mortality”, in Health at a Glance 2021: OECD Indicators. OECD Publishing, Paris (2021): ‹https://www.oecd-ilibrary.org/docserver/6cfe5309-en.pdf?expires=1669697565&id=id&accname=guest&checksum=CF9CB18EEC8681DE695F8836C557098A›, accessed 11 July, 2022.

2. 2) WHO. “All cancers fact sheets (2020)”: ‹https://gco.iarc.fr/today/data/factsheets/cancers/39-All-cancers-fact-sheet.pdf›, accessed 11 July, 2022.

3. 3) Ohno S, Chen Y, Sakamaki H, Matsumaru N, Tsukamoto K. A population-based study of the humanistic burden among cancer patients in Japan. J. Med. Econ., 23, 429–441 (2020).

4. 4) Ohno S, Chen Y, Sakamaki H, Matsumaru N, Tsukamoto K. Humanistic and economic burden among caregivers of patients with cancer in Japan. J. Med. Econ., 23, 17–27 (2020).

5. 5) Centre for Innovation in Regulatory Science. “R&D Briefing 85: New drug approvals in six major authorities 2012–2021: Focus on Facilitated Regulatory Pathways and internationalisation.” Centre for Innovation in Regulatory Science (CIRS), London, U.K. (2022): ‹https://cirsci.org/wp-content/uploads/dlm_uploads/2022/06/CIRS-RD-Briefing-85-6-agencies-v2.3.pdf›, accessed 17 November, 2022.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The emerging role of real-world data in oncology care in Japan;ESMO Real World Data and Digital Oncology;2023-12